{"id":"NCT01973218","sponsor":"Novartis Vaccines","briefTitle":"Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adolescents Aged 11-17 Years.","officialTitle":"A Phase 3, Randomized, Observer-blind, Multicenter Study to Evaluate the Immunogenicity and Safety of Novartis rMenB+OMV NZ Vaccine in Healthy Subjects Aged 11 to 17 Years in Korea","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-11","primaryCompletion":"2014-04","completion":"2014-04","firstPosted":"2013-10-31","resultsPosted":"2015-03-06","lastUpdate":"2015-10-30"},"enrollment":264,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Meningococcal Disease"],"interventions":[{"type":"BIOLOGICAL","name":"Meningococcal B Recombinant vaccine rMenB+OMV NZ","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]},{"type":"BIOLOGICAL","name":"Meningococcal ACWY-CRM conjugate vaccine","otherNames":["Meningococcal (groups A,C,W,and Y) oligosaccharide diphtheria CRM-197"]}],"arms":[{"label":"rMenB","type":"EXPERIMENTAL"},{"label":"Placebo/MenACWY","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study was to assess the immunogenicity and safety of two doses of Novartis Meningococcal B Recombinant (rMenB+OMV NZ) vaccine administered one month apart (0, 1 month schedule) in Korean adolescents aged between 11 to 17 years.","primaryOutcome":{"measure":"Percentage of Subjects With Serum Bactericidal Antibody (SBA) Titers â‰¥1:4 Against Neisseria Meningitidis Serogroup B by Vaccine Group.","timeFrame":"Day 1 and Day 61","effectByArm":[{"arm":"rMenb","deltaMin":26,"sd":null},{"arm":"Placebo/MenACWY","deltaMin":24,"sd":null}],"pValues":[]},"eligibility":{"minAge":"11 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":7,"countries":["South Korea"]},"refs":{"pmids":["26826544"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":174},"commonTop":["INJECTION SITE PAIN","HEADACHE","MALAISE","MYALGIA","INJECTION SITE INDURATION"]}}